Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma
- PMID: 2803908
- PMCID: PMC2247346
- DOI: 10.1038/bjc.1989.230
Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma
Abstract
Flavone acetic acid (FAA), 8.6 gm-2 has been administered by 6h intravenous infusion to 19 patients with advanced colorectal carcinoma and 15 patients with advanced malignant melanoma. The drug associated toxicity was generally mild and as predicted from the phase I study. No responses were seen in either disease.
Similar articles
-
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.Invest New Drugs. 1990;8 Suppl 1:S95-9. doi: 10.1007/BF00171993. Invest New Drugs. 1990. PMID: 2380021
-
Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.Am J Clin Oncol. 1991 Dec;14(6):483-6. doi: 10.1097/00000421-199112000-00005. Am J Clin Oncol. 1991. PMID: 1957836 Clinical Trial.
-
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.J Natl Cancer Inst. 1995 Jan 18;87(2):134-6. doi: 10.1093/jnci/87.2.134. J Natl Cancer Inst. 1995. PMID: 7707385 Clinical Trial. No abstract available.
-
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.Cancer Chemother Pharmacol. 1987;19(1):6-10. doi: 10.1007/BF00296246. Cancer Chemother Pharmacol. 1987. PMID: 3545524 Review.
-
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.Clin Cancer Res. 2005 Aug 15;11(16):5928-34. doi: 10.1158/1078-0432.CCR-05-0130. Clin Cancer Res. 2005. PMID: 16115935 Review.
Cited by
-
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.Jpn J Cancer Res. 1999 Sep;90(9):1016-25. doi: 10.1111/j.1349-7006.1999.tb00850.x. Jpn J Cancer Res. 1999. PMID: 10551333 Free PMC article.
-
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.Drug Metab Lett. 2011 Apr;5(2):73-84. doi: 10.2174/187231211795305221. Drug Metab Lett. 2011. PMID: 21457135 Free PMC article.
-
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies.Br J Cancer. 1993 Jun;67(6):1342-5. doi: 10.1038/bjc.1993.248. Br J Cancer. 1993. PMID: 8512818 Free PMC article. Clinical Trial.
-
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).J Biol Chem. 2010 Apr 2;285(14):10553-62. doi: 10.1074/jbc.M109.065631. Epub 2010 Jan 29. J Biol Chem. 2010. PMID: 20118240 Free PMC article.
-
Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.Br J Cancer. 1995 Jun;71(6):1204-9. doi: 10.1038/bjc.1995.234. Br J Cancer. 1995. PMID: 7779712 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous